Novel compounds of the formula (I) formula (I) in which W, E, X, Y, T, R1, R
2
, R
2′
, and R
2″
are as defined in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders and for the treatment of tumours.
1
公式(I)的新化合物,其中W,E,X,Y,T,R1,R2,R2'和R2''如专利要求书1中所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓性疾病以及肿瘤的治疗。